These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7342700)

  • 1. [Sorptive properties of medicinal charcoal. VI. Suspensions of medicinal charcoal].
    Pawlaczyk J; Sobczak H
    Acta Pol Pharm; 1981; 38(5):617-9. PubMed ID: 7342700
    [No Abstract]   [Full Text] [Related]  

  • 2. Minimal water requirements for suspending powdered antidotal charcoals.
    Cooney DO
    Vet Hum Toxicol; 1995 Dec; 37(6):542-3. PubMed ID: 8588291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced activated charcoal delivery through small-bore tubing.
    Schneider SM; Michelson EA
    Vet Hum Toxicol; 1993 Dec; 35(6):503-5. PubMed ID: 8303817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Container residue after the administration of aqueous activated charcoal products.
    Krenzelok EP; Lush RM
    Am J Emerg Med; 1991 Mar; 9(2):144-6. PubMed ID: 1994942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kerr Insta-Char activated charcoal product.
    Krenzelok EP
    Am J Emerg Med; 1992 May; 10(3):265. PubMed ID: 1586442
    [No Abstract]   [Full Text] [Related]  

  • 6. [The significance of the form of preparation for the degree of adsorption of medical charcoal].
    Otto U; Stenberg B
    Lakartidningen; 1973 Aug; 70(31):2729-30. PubMed ID: 4786756
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of activated charcoal on rifampicin absorption in man.
    Orisakwe OE; Dioka CE; Okpogba AN; Orish CN; Ofoefule SI
    Tokai J Exp Clin Med; 1996 Feb; 21(1):51-4. PubMed ID: 9239805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the adsorption capacities of an activated-charcoal--yogurt mixture versus activated-charcoal--water slurry in vivo and in vitro.
    Hoegberg LC; Christophersen AB; Christensen HR; Angelo HR
    Clin Toxicol (Phila); 2005; 43(4):269-75. PubMed ID: 16035203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased phenobarbital absorption with charcoal administration for chronic renal failure.
    Tanaka C; Yagi H; Sakamoto M; Koyama Y; Ohmura T; Ohtani H; Sawada Y
    Ann Pharmacother; 2004 Jan; 38(1):73-6. PubMed ID: 14742799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel methods for storage stability and release of Bacillus spores.
    Sorokulova IB; Krumnow AA; Pathirana S; Mandell AJ; Vodyanoy V
    Biotechnol Prog; 2008; 24(5):1147-53. PubMed ID: 19194925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the palatability of activated charcoal in pediatric patients.
    Cheng A; Ratnapalan S
    Pediatr Emerg Care; 2007 Jun; 23(6):384-6. PubMed ID: 17572522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of medicinal coal in primary management of poisoning].
    Brockstedt M; Hoffmann-Walbeck P
    Kinderarztl Prax; 1993 Dec; 61(10):378-81. PubMed ID: 8145456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Container residue of activated charcoal products.
    Harchelroad F
    Am J Emerg Med; 1991 Sep; 9(5):520. PubMed ID: 1863306
    [No Abstract]   [Full Text] [Related]  

  • 14. [Measurement of flow and analysis of rectal gas after a test meal of beans and onions. Description of the method and double-blind study of activated charcoal].
    Bigard MA; Gilbert C; Bloom M
    Gastroenterol Clin Biol; 1989 Mar; 13(3):312-3. PubMed ID: 2731683
    [No Abstract]   [Full Text] [Related]  

  • 15. Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs.
    Lapatto-Reiniluoto O; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2001 Sep; 70(3):255-60. PubMed ID: 11557913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability and uniformity of extemporaneous preparations of voriconazole in two liquid suspension vehicles at two storage temperatures.
    Nguyen KQ; Hawkins MG; Taylor IT; Wiebe VJ; Tell LA
    Am J Vet Res; 2009 Jul; 70(7):908-14. PubMed ID: 19566477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative efficacy and palatability of three activated charcoal mixtures.
    Navarro RP; Navarro KR; Krenzelok EP
    Vet Hum Toxicol; 1980 Feb; 22(1):6-9. PubMed ID: 7361450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of azacitidine suspensions.
    Duriez A; Vigneron JH; Zenier HA; May I; Demoré BM
    Ann Pharmacother; 2011 Apr; 45(4):546. PubMed ID: 21487087
    [No Abstract]   [Full Text] [Related]  

  • 19. Stability of extemporaneous enalapril maleate suspensions for pediatric use prepared from commercially available tablets.
    Sosnowska K; Winnicka K; Czajkowska-Kośnik A
    Acta Pol Pharm; 2009; 66(3):321-6. PubMed ID: 19645333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractional contribution of lung, nasal and gastrointestinal absorption to the systemic level following nose-only aerosol exposure in rats: a case study of 3.7- micro m fluorescein aerosols.
    Sakagami M; Kinoshita W; Sakon K; Makino Y
    Arch Toxicol; 2003 Jun; 77(6):321-9. PubMed ID: 12799771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.